Connect Biopharma Holdings Limited (CNTB)’in fiyatı nedir?

Connect Biopharma Holdings Limited (CNTB)’in fiyatı $2.42’dir

Connect Biopharma Holdings Limited (CNTB)’in piyasa değeri nedir?

Connect Biopharma Holdings Limited (CNTB)’in piyasa değeri $152.37M’dir.

Connect Biopharma Holdings Limited (CNTB) Fiyat Geçmişi

Connect Biopharma Holdings Limited is a clinical-stage biopharmaceutical company dedicated to discovering and advancing immune modulators. Its primary objective is to develop treatments for serious autoimmune diseases and various inflammatory conditions. The company's lead investigational therapy is CBP-201, an anti-interleukin-4 receptor alpha antibody. This candidate is currently in Phase IIb clinical trials, targeting inflammatory allergic diseases such as atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. Additionally, Connect Biopharma's pipeline includes CBP-307, a small molecule designed to modulate sphingosine 1-phosphate receptor 1. This receptor plays a crucial role in regulating T cell movement from lymph nodes into the bloodstream. CBP-307 is in Phase II development for treating autoimmune-related inflammatory disorders. Another preclinical-stage asset, CBP-174, is an orally administered small molecule histamine receptor 3 antagonist, being investigated for chronic pruritus (itch) associated with skin inflammation. The portfolio also features CBP-233, a humanized antibody in preclinical development that targets interleukin-33, a cytokine recognized for its involvement in T helper 2 inflammation. Established in 2012, the company maintains its headquarters in Taicang, China.

Yıl	Performans
2026 (TTM)	-8.60%
2025	129.78%
2024	18.63%
2023	21.12%
2022	-83.36%
2021	0.00%

Yıl

Performans

2026 (TTM)

-8.60%

2025

129.78%

2024

18.63%

2023

21.12%

2022

-83.36%

2021

0.00%

Şirket	Hisse fiyatı	Değişim 1yıl%	Ülke
Vertex Pharmaceuticals Incorporated VRTX.US	$553.09	42.85%	US
Argenx SE ARGX.US	$1.02K	44.02%	NL
Moderna, Inc. MRNA.US	$158.64	541.49%	US
CSL Limited CSL.AX	$123.02	-11.98%	AU
Lonza Group AG LONN.SW	$772.27	7.33%	CH

Şirket

Hisse fiyatı

Değişim 1yıl%

Ülke